Globus Medical reported 11.5 percent increase in net sales for the second quarter of 2013 and a 10.8 percent increase in U.S. sales over the same period of last year.
However, net income for the quarter was $7.4 million, a drop from $19 million last year. The company remains debt free. During the second quarter, Globus Medical launched six new products, including the first laterally expanding unitary interbody fusion spacer, the LATIS.
More Articles on Spine Surgeons:
12 Spine Surgeons Leading Large Hospital-Based Spine Centers
4 Tips for spine Surgeons to Make a God Impression From Dr. Christopher Sliva
Dr. Lawrence Lenke Receives Leon Wiltse Award From NASS